BioPlus Co., Ltd. (099430) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for BioPlus Co., Ltd. (099430:KRX), powered by AI.

Current Price
₩4,580
P/E Ratio
18.8
Market Cap
282.3B
Sector
Healthcare
What is the BioPlus Co., Ltd. stock price forecast?

BioPlus Co., Ltd. is currently trading at ₩4,580. View real-time AI analysis on Alpha Lenz.

What is BioPlus Co., Ltd. insider trading activity?

View the latest insider trading data for BioPlus Co., Ltd. on Alpha Lenz.

What is BioPlus Co., Ltd.'s P/E ratio?

BioPlus Co., Ltd.'s P/E ratio is 18.8.

BioPlus Co., Ltd.

KRX · 099430
₩4,580-25(-0.54%)Market closedKRX regular session 09:00–15:30 KST
Ask about BioPlus Co., Ltd.'s future dividend policy...
Alpha Chat Insight

BioPlus Co., Ltd. trades at a P/E of 18.8 (fair value) with solid ROE of 9.7%. 3Y revenue CAGR of 17.0% highlights clear growth momentum.

Ask for details

Company Overview

BioPlus Co., Ltd. specializes in the production and distribution of biopolymer-based aesthetic and therapeutic products. As a company operating at the forefront of biotechnology, its primary focus is on developing dermal fillers and absorbable barrier membranes primarily used in cosmetic and medical procedures. BioPlus Co., Ltd. significantly impacts the cosmetic and healthcare sectors by providing innovative solutions that enhance skin aesthetics and facilitate postoperative recovery. The company integrates cutting-edge technology and research to drive advancements in biopolymer applications, ensuring safety and efficacy for end-users. Established as a key player in the life sciences industry, BioPlus Co., Ltd. continues to contribute to the growing demand for non-surgical cosmetic enhancements and medical products, cementing its role within the rapidly evolving biotechnology market.

CEO정현규
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees121

Company Statistics

FY 2025

Profile

₩282,314,506,760Market Cap
₩90,896,012,970Revenue
61.64MShares Out
121Employees

Margins

66.68%Gross
21.83%EBITDA
16.51%Operating
19.29%Pre-Tax
22.00%Net

Valuation

18.82P/E
1.61P/B
3.11EV/Sales
17.21EV/EBITDA
-8.51P/FCF

Growth (CAGR)

17.02%Rev 3Yr
30.12%Rev 5Yr
-15.95%Op Inc 3Yr
4.01%Op Inc 5Yr
-1.16%Net Inc 3Yr
15.56%Net Inc 5Yr

Returns

7.28%ROA
9.73%ROE
6.50%ROIC

Financial Health

₩21,107,628,060Cash & Cash Equivalents
₩68,952,874,060Net Debt
46.19%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

BioPlus Co., Ltd. (ticker: 099430) is a company listed on KRX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 121 employees. Market cap is $282.3B.

The current price is ₩4,580 with a P/E ratio of 18.82x and P/B of 1.61x.

ROE is 9.73% and operating margin is 16.51%. Annual revenue is $90.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
BioPlus Co., Ltd. (099430) Stock Forecast 2026 ₩4,580 — Price, Financials & Analyst Targets | Alpha Lenz